References
Schena FP (2011) Management of patients with chronic kidney disease. Intern Emerg Med 6(Suppl 1):77–83
Simonsen E, Komenda P, Lerner B et al (2017) Treatment of uremic pruritus: a systematic review. Am J Kidney Dis 70(5):638–655
Stander S, Weisshaar E, Mettang T et al (2007) Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 87(4):291–294
Casino FG, Lopez T (1996) The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Renal Assoc 11(8):1574–1581
Friedman LM, Furberg C, DeMets DL (1998) Fundamentals of clinical trials, 3rd edn. Springer, New York
Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H (2004) Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Renal Assoc 19(12):3137–3139
Manenti L, Vaglio A, Costantino E et al (2005) Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation. J Nephrol 18(1):86–91
Naini AE, Harandi AA, Khanbabapour S, Shahidi S, Seirafiyan S, Mohseni M (2007) Gabapentin: a promising drug for the treatment of uremic pruritus. Saudi J Kidney Dis Transpl 18(3):378–381
Pongcharoen P, Fleischer AB Jr (2016) An evidence-based review of systemic treatments for itch. Eur J Pain 20(1):24–31
Collins SL, Moore RA, McQuay HJ (1997) The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 72(1–2):95–97
Pauli-Magnus C, Mikus G, Alscher DM et al (2000) Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 11(3):514–519
(U.S.) NCI (2009) Common terminology criteria for adverse events (CTCAE). Rev. ed. U.S. Dept. of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda
Nofal E, Farag F, Nofal A, Eldesouky F, Alkot R, Abdelkhalik Z (2016) Gabapentin: a promising therapy for uremic pruritus in hemodialysis patients: a randomized-controlled trial and review of literature. J Dermatol Treat 27(6):515–519
Solak Y, Biyik Z, Atalay H et al (2012) Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. Nephrology (Carlton) 17(8):710–717
Manenti L, Tansinda P, Vaglio A (2009) Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs 69(3):251–263
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Statement of human and animal rights
All procedures were approved by the Azienda Ospedaliera S. Maria Nuova of Reggio Emilia Ethical Committee, and were compliant with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
All participants provided informed consent prior to their participation.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rossi, G.M., Corradini, M., Blanco, V. et al. Randomized trial of two after-dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients. Intern Emerg Med 14, 1341–1346 (2019). https://doi.org/10.1007/s11739-019-02175-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-019-02175-4